Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TXTM Relative to the S&P 500

TXTM Relative to the Sector

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Protext Pharma Inc. (OTCMKT:TXTM) seasonal charts above shows that a Buy Date of November 19 and a Sell Date of March 1 has resulted in a geometric average return of 71.87% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 104.25% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

ProText Mobility, Inc. engages in the development of pharmaceutical applications for botanical drugs. It has license to develop Phytofare, which is a bioavailable extract produced from live green tea leaves that has been clinically proven in double-blind human trials to have ten-times greater bioavailability over generic extract. The company was founded by Ahmed Jamaloodeen & Dylon Du Plooy on September 5, 2001 and is headquartered in Fort Lauderdale, FL.

To download TXTM seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TXTM